ZA855224B - Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use - Google Patents

Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use

Info

Publication number
ZA855224B
ZA855224B ZA855224A ZA855224A ZA855224B ZA 855224 B ZA855224 B ZA 855224B ZA 855224 A ZA855224 A ZA 855224A ZA 855224 A ZA855224 A ZA 855224A ZA 855224 B ZA855224 B ZA 855224B
Authority
ZA
South Africa
Prior art keywords
ylphenyldihydropyridazinones
pyrrol
preparation
disorders
novel
Prior art date
Application number
ZA855224A
Other languages
English (en)
Inventor
Karl-Heinz Geiss
Bernhard Schmied
Manfred Raschack
Hans-Dieter Lehmann
Josef Gries
Klaus Ruebsamen
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA855224B publication Critical patent/ZA855224B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Detergent Compositions (AREA)
ZA855224A 1984-07-12 1985-07-11 Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use ZA855224B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843425632 DE3425632A1 (de) 1984-07-12 1984-07-12 (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ZA855224B true ZA855224B (en) 1986-03-26

Family

ID=6240427

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA855224A ZA855224B (en) 1984-07-12 1985-07-11 Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use

Country Status (12)

Country Link
US (1) US4710496A (fi)
EP (1) EP0167995B1 (fi)
JP (1) JPS6169775A (fi)
AT (1) ATE39694T1 (fi)
AU (1) AU4482985A (fi)
CA (1) CA1248947A (fi)
DE (2) DE3425632A1 (fi)
DK (1) DK317285A (fi)
ES (1) ES8604570A1 (fi)
FI (1) FI81347C (fi)
NO (1) NO162557C (fi)
ZA (1) ZA855224B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
IL79280A (en) * 1985-07-05 1990-07-12 Smith Kline French Lab 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them
DE3600275A1 (de) * 1986-01-08 1987-07-09 Basf Ag Substituierte pyrrol-1-ylphenyldihydropyridazinone, ihre herstellung und verwendung
DE3626865A1 (de) * 1986-08-08 1988-02-11 Boehringer Mannheim Gmbh Neue pyridazinon-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
US4806535A (en) * 1987-07-22 1989-02-21 Rorer Pharmaceutical Corporation Imidazolylphenyl and 1,2,4-triazolylphenyl benzopyridazinone and pyridopyridazinone compounds and their use for increasing cardiatonic contractility
DE3735207A1 (de) * 1987-10-17 1989-04-27 Basf Ag Mittel auf der basis von phenylpyridazinon-derivaten zur wachstumsfoerderung und fettreduktion bei tieren
DE3804490A1 (de) * 1988-02-12 1989-08-24 Heumann Pharma Gmbh & Co Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
WO2020157199A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft Annulated dihydropyridazinone compounds as anti-cancer compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones

Also Published As

Publication number Publication date
JPS6169775A (ja) 1986-04-10
AU4482985A (en) 1986-01-16
FI852730A0 (fi) 1985-07-10
EP0167995B1 (de) 1989-01-04
DK317285D0 (da) 1985-07-11
DK317285A (da) 1986-01-13
FI81347B (fi) 1990-06-29
FI81347C (fi) 1990-10-10
DE3425632A1 (de) 1986-01-16
CA1248947A (en) 1989-01-17
ES545155A0 (es) 1986-02-01
ATE39694T1 (de) 1989-01-15
DE3567211D1 (en) 1989-02-09
EP0167995A3 (en) 1986-12-10
US4710496A (en) 1987-12-01
NO162557C (no) 1990-01-17
ES8604570A1 (es) 1986-02-01
FI852730L (fi) 1986-01-13
NO162557B (no) 1989-10-09
EP0167995A2 (de) 1986-01-15
NO852793L (no) 1986-01-13

Similar Documents

Publication Publication Date Title
ZA857274B (en) Diarylacetylenes,their preparation and their use
EP0176032A3 (en) Tetralin derivatives, their preparation and use
GR77437B (fi)
HK1011987A1 (en) Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines
DE3563533D1 (en) Derivatives of glycerophosphocholine and of glycerophosphoethanol amine, their preparation and use
ZA864041B (en) Pyridine derivatives,their preparation and their use
ZA857275B (en) 1-substituted tetralin derivatives,their preparation and their use
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
GB2177398B (en) 5,6-epoxy-7-oxabicycloheptane substituted ethers useful in the treatment of thrombotic disease
ES8707734A1 (es) Procedimiento para la obtencion de cefalosporinas
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
ZA796789B (en) Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds
ZA823602B (en) N-substituted 2-methylnaphthylamides, their preparation, and their use for controlling fungi
DE3666433D1 (en) 4-substituted 10-cyanomethylene-thienoû4,3-e¨-benzo-azepines
DE3362130D1 (en) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines, their preparation and use
IE820765L (en) Dihydro-alkylene-morphanthridin-6-ones
EP0292820A3 (en) 3-phenyl-2-styryl-pyrrolidines, their preparation and use
ES8705401A1 (es) Un procedimiento para la obtencion de 1.4-dihidropirazinas
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments